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Background:  The Canadian Heart Failure Network (CHFN) of multidisciplinary HF outpatient clinics (n=26) have enrolled and followed HF patients 
in both academic and community centers from 1999 to 2009. Treatment was guided by the Canadian Cardiovascular Society HF Guidelines.
Methods:  A common electronic database was used to collect patient data and conduct analyses of patient management and outcomes. We 
describe the five year survival of these ambulatory HF outpatients by their NYHA class at CHFN first visit and by the influence of key risk factors.
Results:  13,361 HF patients at least 18 yrs of age, with at least 2 follow-up assessments, were identified. 2,771 (20.7%) patients died during the 
5 year period of follow-up. At the time of their first CHFN outpatient visit, 12.1% were NYHA class I, 40.3% Class II, 43.2% Class III, and 4.4% Class 
IV. Based on NYHA class and univariable associations, proportional hazard survival curves (Kaplan Meier) were derived. With NYHA Class I as the 
reference, the hazard ratio for Class II was 1.71 (CI’s 1.42, 2.05), Class III was 3.69 (3.09, 4.40), and Class IV 5.98 (4.85, 7.37).
Conclusions:  Although NYHA Class can change over time, NYHA Class at the time of first data entry into the CFHN longitudinal database remains 
a powerful predictor of survival in this ambulatory population of contemporary HF patients being treated according to current guidelines. New 
therapeutic approaches for NYHA Class III-IV are urgently required to reduce this persistent high mortality. 
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